Pay in 4 interest-free payments of $6.39 Learn more
Ships within 48 hours · Estimated delivery Aug 18 - Aug 23
The 48-week, randomized, double-blind, placebo-controlled study enrolled 469 adults with obesity or overweight with at least one weight-related comorbidity and evaluated multiple dose escalation regimens up to 24 mg administered subcutaneously once weekly
Whatever you do, avoid squeezing spots or you may spread bacteria and further aggravate your skin, or even end up with scars
K.BrenhouseH
Manufacturers cannot legally claim weight loss or therapeutic benefits on the label or marketing materials without FDA approval or an Investigational New Drug (IND) application
US$ 27.64
US$ 25.88
US$ 26.08
US$ 23.23
US$ 26.11
